Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
0.9244
-0.0374 (-3.89%)
At close: Apr 17, 2025, 4:00 PM
0.9450
+0.0206 (2.23%)
After-hours: Apr 17, 2025, 4:37 PM EDT
INZY's stock price has decreased by -80.94% in the past year and price targets may not have had time to catch up.
Inozyme Pharma Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$17.22
Upside
+1,762.83%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +1,630.85% | Apr 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +1,522.67% | Apr 8, 2025 |
| Raymond James | Raymond James | Buy Maintains $24 → $12 | Buy | Maintains | $24 → $12 | +1,198.14% | Mar 12, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 → $23 | Buy | Maintains | $30 → $23 | +2,388.10% | Mar 11, 2025 |
| Needham | Needham | Strong Buy Maintains $23 → $15 | Strong Buy | Maintains | $23 → $15 | +1,522.67% | Mar 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +1,630.85% | Mar 11, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $43 → $30 | Buy | Maintains | $43 → $30 | +3,145.35% | Jan 13, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +1,089.96% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +1,630.85% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +1,630.85% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +1,414.50% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +2,388.10% | Nov 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +2,388.10% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +1,414.50% | Oct 25, 2024 |
| Wedbush | Wedbush | Buy Reiterates $15 | Buy | Reiterates | $15 | +1,522.67% | Sep 30, 2024 |
| Stifel | Stifel | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +1,630.85% | Sep 12, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.